{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:22:14Z","timestamp":1768317734162,"version":"3.49.0"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Salusins are discovered in 2003 and divided into salusin-\u03b1 and salusin-\u03b2, which are bioactive peptides with hemodynamic and mitotic activity and mainly distributed in plasma, urine, endocrine glands and kidneys. A large number of studies have shown that salusins can regulate lipid metabolism, inflammatory response and vascular proliferation. Despite the profound and diverse physiological properties of salusins, the exact mechanism of their cardiovascular effects remains to be determined. The potential mechanisms of action of salusins in cardiovascular-related diseases such as atherosclerosis, hypertension, heart failure, myocardial infarction and myocarditis, and their use as biomarkers of cardiovascular disease are discussed. This review aims to provide a new strategy for the diagnosis and prevention of clinical cardiovascular diseases.<\/jats:p>","DOI":"10.1093\/jpp\/rgac087","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T18:01:43Z","timestamp":1670868103000},"page":"363-369","source":"Crossref","is-referenced-by-count":11,"title":["Salusins: advance in cardiovascular disease research"],"prefix":"10.1093","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1026-6625","authenticated-orcid":false,"given":"Ming-xin","family":"Chen","sequence":"first","affiliation":[{"name":"Institute of Pharmacy and Pharmacology, University of South China , Hengyang ,","place":["China"]},{"name":"Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China , Hengyang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-yan","family":"Deng","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy and Pharmacology, University of South China , Hengyang ,","place":["China"]},{"name":"Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China , Hengyang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-ting","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy and Pharmacology, University of South China , Hengyang ,","place":["China"]},{"name":"Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China , Hengyang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zong-bao","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy and Pharmacology, University of South China , Hengyang ,","place":["China"]},{"name":"Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China , Hengyang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3573-6638","authenticated-orcid":false,"given":"Shu-zhi","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy and Pharmacology, University of South China , Hengyang ,","place":["China"]},{"name":"Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China , Hengyang ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"2024103012211151200_CIT0001","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.ATV.20.4.989","article-title":"Endothelin-1 inhibits apoptosis of vascular smooth muscle cells induced by nitric oxide and serum deprivation via MAP kinase pathway","volume":"20","author":"Shichiri","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024103012211151200_CIT0002","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/sj.gt.3301953","article-title":"Intravenous gene therapy for familial hypercholesterolemia using ligand-facilitated transfer of a liposome:LDL receptor gene complex","volume":"10","author":"Shichiri","year":"2003","journal-title":"Gene Ther"},{"key":"2024103012211151200_CIT0003","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nm913","article-title":"Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities","volume":"9","author":"Shichiri","year":"2003","journal-title":"Nat Med"},{"key":"2024103012211151200_CIT0004","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ng0997-40","article-title":"The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein","volume":"17","author":"Ozelius","year":"1997","journal-title":"Nat Genet"},{"key":"2024103012211151200_CIT0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/geno.1999.6039","article-title":"The TOR1A (DYT1) gene family and its role in early onset torsion dystonia","volume":"62","author":"Ozelius","year":"1999","journal-title":"Genomics"},{"key":"2024103012211151200_CIT0006","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/01.HYP.0000156496.15668.62","article-title":"Synthetic salusins as cardiac depressors in rat","volume":"45","author":"Izumiyama","year":"2005","journal-title":"Hypertension"},{"key":"2024103012211151200_CIT0007","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/10520295.2013.821167","article-title":"Salusin-alpha and -beta expression in heart and aorta with and without metabolic syndrome","volume":"89","author":"Aydin","year":"2014","journal-title":"Biotech Histochem"},{"key":"2024103012211151200_CIT0008","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.regpep.2010.03.009","article-title":"Serum levels and urinary excretion of salusin-alpha in renal insufficiency","volume":"162","author":"Kimoto","year":"2010","journal-title":"Regul Pept"},{"key":"2024103012211151200_CIT0009","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.peptides.2009.03.021","article-title":"Expression of prosalusin in human neuroblastoma cells","volume":"30","author":"Nakayama","year":"2009","journal-title":"Peptides"},{"key":"2024103012211151200_CIT0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clinbiochem.2020.10.003","article-title":"The importance of circulating levels of salusin-alpha, salusin-beta, and heregulin-beta1 in atherosclerotic coronary arterial disease","volume":"87","author":"Arkan","year":"2021","journal-title":"Clin Biochem"},{"key":"2024103012211151200_CIT0011","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"2024103012211151200_CIT0012","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.atherosclerosis.2013.02.028","article-title":"Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis","volume":"228","author":"van Diepen","year":"2013","journal-title":"Atherosclerosis"},{"key":"2024103012211151200_CIT0013","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3892\/ol.2015.4017","article-title":"Risk factors of atherosclerosis during systemic therapy targeting vascular endothelial growth factor","volume":"11","author":"Studentova","year":"2016","journal-title":"Oncol Lett"},{"issue":"3","key":"2024103012211151200_CIT0014","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1123\/pes.2020-0138","article-title":"Effectiveness of continuous aerobic versus high-intensity interval training on atherosclerotic and inflammatory markers in boys with overweight\/obesity","volume":"33","author":"Paahoo","year":"2021","journal-title":"Pediatr Exerc Sci"},{"key":"2024103012211151200_CIT0015","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.2174\/1381612824666180607124531","article-title":"Correlation of salusin beta with hs-CRP and ADMA in hypertensive children and adolescents","volume":"24","author":"Kolakowska","year":"2018","journal-title":"Curr Pharm Des"},{"key":"2024103012211151200_CIT0016","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00405-021-06804-7","article-title":"The role of serum salusin alpha and beta levels and atherosclerotic risk factors in idiopathic sudden hearing loss pathogenesis","volume":"279","author":"Genc Elden","year":"2022","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2024103012211151200_CIT0017","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1159\/000430207","article-title":"Effect of salusin-beta on peroxisome proliferator-activated receptor gamma gene expression in vascular smooth muscle cells and its possible mechanism","volume":"36","author":"Xu","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"2024103012211151200_CIT0018","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1089\/ars.2015.6475","article-title":"Salusin-beta promotes vascular smooth muscle cell migration and intimal hyperplasia after vascular injury via ROS\/NFkappaB\/MMP-9 pathway","volume":"24","author":"Sun","year":"2016","journal-title":"Antioxid Redox Signal"},{"key":"2024103012211151200_CIT0019","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.regpep.2010.02.010","article-title":"Release of salusin-beta from human monocytes\/macrophages","volume":"162","author":"Sato","year":"2010","journal-title":"Regul Pept"},{"key":"2024103012211151200_CIT0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/10641963.2020.1797086","article-title":"Assessment of salusin alpha and salusin beta levels in patients with newly diagnosed dipper and non-dipper hypertension","volume":"43","author":"Alpsoy","year":"2021","journal-title":"Clin Exp Hypertens"},{"key":"2024103012211151200_CIT0021","first-page":"177","article-title":"Relationship of serum salusin beta levels with coronary slow flow","volume":"22","author":"Akyuz","year":"2019","journal-title":"Anatol J Cardiol"},{"key":"2024103012211151200_CIT0022","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/00365513.2013.783227","article-title":"Serum salusin-alpha levels are inversely correlated with the presence and severity of coronary artery disease","volume":"73","author":"Du","year":"2013","journal-title":"Scand J Clin Lab Invest"},{"key":"2024103012211151200_CIT0023","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2174\/13892037113149990064","article-title":"Emerging roles for vasoactive peptides in diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseases","volume":"14","author":"Watanabe","year":"2013","journal-title":"Curr Protein Pept Sci"},{"key":"2024103012211151200_CIT0024","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.3390\/s120404974","article-title":"Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease","volume":"12","author":"Watanabe","year":"2012","journal-title":"Sensors (Basel)"},{"key":"2024103012211151200_CIT0025","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.18632\/aging.102678","article-title":"Increased serum salusin-\u03b1 by aerobic exercise training correlates with improvements in arterial stiffness in middle-aged and older adults","volume":"12","author":"Fujie","year":"2020","journal-title":"Aging"},{"issue":"1","key":"2024103012211151200_CIT0026","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/01480545.2019.1683572","article-title":"Salusin-\u03b1 mitigates diabetic nephropathy via inhibition of the Akt\/mTORC1\/p70S6K signaling pathway in diabetic rats","volume":"45","author":"Wang","year":"2022","journal-title":"Drug Chem Toxicol"},{"key":"2024103012211151200_CIT0027","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1291\/hypres.31.463","article-title":"Serum salusin-alpha levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients","volume":"31","author":"Watanabe","year":"2008","journal-title":"Hypertens Res"},{"key":"2024103012211151200_CIT0028","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00467-014-2960-y","article-title":"Is the serum level of salusin-beta associated with hypertension and atherosclerosis in the pediatric population?","volume":"30","author":"Kolakowska","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"2024103012211151200_CIT0029","doi-asserted-by":"crossref","first-page":"443","DOI":"10.20452\/pamw.2401","article-title":"Effect of lifestyle changes and atorvastatin administration on dyslipidemia in hemodialysis patients a prospective study","volume":"124","author":"Grzegorzewska","year":"2014","journal-title":"Pol Arch Med Wewn"},{"key":"2024103012211151200_CIT0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejphar.2018.04.026","article-title":"Salusin-alpha attenuates hepatic steatosis and atherosclerosis in high fat diet-fed low density lipoprotein receptor deficient mice","volume":"830","author":"Tang","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"2024103012211151200_CIT0031","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1016\/j.febslet.2006.08.022","article-title":"Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development","volume":"580","author":"Pennings","year":"2006","journal-title":"FEBS Lett"},{"key":"2024103012211151200_CIT0032","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/CIRCRESAHA.109.193870","article-title":"Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis","volume":"105","author":"Xu","year":"2009","journal-title":"Circ Res"},{"key":"2024103012211151200_CIT0033","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/CIRCULATIONAHA.107.712539","article-title":"Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis","volume":"117","author":"Watanabe","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"2024103012211151200_CIT0034","first-page":"268","article-title":"Salusin-\u03b1 inhibits THP-1 derived foam cell formation via PPAR\u03b3 pathway","volume":"48","author":"Liu","year":"2019","journal-title":"Acta Med Univ Sci Technol Huazhong"},{"key":"2024103012211151200_CIT0035","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MOL.0000000000000113","article-title":"Smooth muscle cell phenotypic switch: implications for foam cell formation","volume":"25","author":"Chaabane","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"2024103012211151200_CIT0036","first-page":"680","article-title":"Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits","volume":"10","author":"Rosenfeld","year":"1990","journal-title":"Arteriosclerosis (Dallas, Tex.)"},{"key":"2024103012211151200_CIT0037","doi-asserted-by":"crossref","first-page":"23596","DOI":"10.1038\/srep23596","article-title":"Salusin-beta induces foam cell formation and monocyte adhesion in human vascular smooth muscle cells via miR155\/NOX2\/NFkappaB pathway","volume":"6","author":"Sun","year":"2016","journal-title":"Sci Rep"},{"key":"2024103012211151200_CIT0038","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature06796","article-title":"Translating molecular discoveries into new therapies for atherosclerosis","volume":"451","author":"Rader","year":"2008","journal-title":"Nature"},{"key":"2024103012211151200_CIT0039","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.113.003008","article-title":"Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation","volume":"128","author":"Varbo","year":"2013","journal-title":"Circulation"},{"key":"2024103012211151200_CIT0040","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/eurheartj\/ehs148","article-title":"Phospholipase A2 enzymes and the risk of atherosclerosis","volume":"33","author":"Rosenson","year":"2012","journal-title":"Eur Heart J"},{"key":"2024103012211151200_CIT0041","doi-asserted-by":"crossref","first-page":"H96","DOI":"10.1152\/ajpheart.00009.2012","article-title":"Salusin-beta accelerates inflammatory responses in vascular endothelial cells via NF-kappaB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro","volume":"303","author":"Koya","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024103012211151200_CIT0042","first-page":"1","article-title":"The effect of salusin-beta on expression of pro- and anti-inflammatory cytokines in human umbilical vein endothelial cells (HUVECs)","volume":"14","author":"Esfahani","year":"2018","journal-title":"ARYA Atheroscler"},{"key":"2024103012211151200_CIT0043","doi-asserted-by":"crossref","first-page":"e91468","DOI":"10.1371\/journal.pone.0091468","article-title":"Salusin-beta not salusin-alpha promotes vascular inflammation in ApoE-deficient mice via the I-kappaBalpha\/NF-kappaB pathway","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"},{"key":"2024103012211151200_CIT0044","doi-asserted-by":"crossref","first-page":"e107555","DOI":"10.1371\/journal.pone.0107555","article-title":"Salusin-beta, but not salusin-alpha, promotes human umbilical vein endothelial cell inflammation via the p38 MAPK\/JNK-NF-kappaB pathway","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"},{"key":"2024103012211151200_CIT0045","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1134\/S0006297917110098","article-title":"Salusin-alpha attenuates inflammatory responses in vascular endothelial cells","volume":"82","author":"Esfahani","year":"2017","journal-title":"Biochemistry (Mosc)"},{"key":"2024103012211151200_CIT0046","first-page":"364","article-title":"The failure of inflammation resolution promotes the progression of atherosclerotic lesions into unstable plaques","volume":"33","author":"Tang","year":"2017","journal-title":"Immunol J"},{"key":"2024103012211151200_CIT0047","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.bbadis.2015.05.008","article-title":"Salusin-beta contributes to vascular remodeling associated with hypertension via promoting vascular smooth muscle cell proliferation and vascular fibrosis","volume":"1852","author":"Sun","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"2024103012211151200_CIT0048","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1089\/ars.2019.7723","article-title":"Salusin-beta promotes vascular calcification via nicotinamide adenine dinucleotide phosphate\/reactive oxygen species-mediated klotho downregulation","volume":"31","author":"Sun","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"2024103012211151200_CIT0049","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/FJC.0000000000000209","article-title":"Salusin-beta induces smooth muscle cell proliferation by regulating cyclins D1 and E expression through MAPKs signaling pathways","volume":"65","author":"Xu","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"key":"2024103012211151200_CIT0050","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1159\/000494792","article-title":"Salusin-alpha inhibits proliferation and migration of vascular smooth muscle cell via Akt\/mTOR signaling","volume":"50","author":"Gao","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"2024103012211151200_CIT0051","doi-asserted-by":"crossref","first-page":"8973986","DOI":"10.1155\/2018\/8973986","article-title":"Overexpression of salusin-alpha inhibits vascular intimal hyperplasia in an atherosclerotic rabbit model","volume":"2018","author":"Qian","year":"2018","journal-title":"Biomed Res Int"},{"key":"2024103012211151200_CIT0052","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/cvr\/cvt031","article-title":"Salusin-\u03b2 in paraventricular nucleus increases blood pressure and sympathetic outflow via vasopressin in hypertensive rats","volume":"98","author":"Chen","year":"2013","journal-title":"Cardiovasc Res"},{"key":"2024103012211151200_CIT0053","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/FJC.0000000000000284","article-title":"Blockade of salusin-beta in hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy in salt-induced hypertensive rats","volume":"66","author":"Li","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"key":"2024103012211151200_CIT0054","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/HJH.0000000000000143","article-title":"Salusin-beta in rostral ventrolateral medulla increases sympathetic outflow and blood pressure via superoxide anions in hypertensive rats","volume":"32","author":"Zhang","year":"2014","journal-title":"J Hypertens"},{"key":"2024103012211151200_CIT0055","doi-asserted-by":"crossref","first-page":"622954","DOI":"10.3389\/fphys.2021.622954","article-title":"Improvement of vascular function by knockdown of salusin-beta in hypertensive rats via nitric oxide and reactive oxygen species signaling pathway","volume":"12","author":"Pan","year":"2021","journal-title":"Front Physiol"},{"key":"2024103012211151200_CIT0056","doi-asserted-by":"crossref","first-page":"11162","DOI":"10.1038\/srep11162","article-title":"Central blockade of salusin beta attenuates hypertension and hypothalamic inflammation in spontaneously hypertensive rats","volume":"5","author":"Li","year":"2015","journal-title":"Sci Rep"},{"key":"2024103012211151200_CIT0057","doi-asserted-by":"crossref","first-page":"43259","DOI":"10.1038\/srep43259","article-title":"Silencing salusin-beta attenuates cardiovascular remodeling and hypertension in spontaneously hypertensive rats","volume":"7","author":"Ren","year":"2017","journal-title":"Sci Rep"},{"key":"2024103012211151200_CIT0058","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/jhh.2011.71","article-title":"Associations of serum salusin-alpha levels with atherosclerosis and left ventricular diastolic dysfunction in essential hypertension","volume":"26","author":"Ti","year":"2012","journal-title":"J Hum Hypertens"},{"key":"2024103012211151200_CIT0059","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1017\/S1047951119001173","article-title":"Salusin-\u03b1 levels are negatively correlated with diastolic blood pressure in children with obesity","volume":"29","author":"Dervi\u015fo\u011flu","year":"2019","journal-title":"Cardiol Young"},{"key":"2024103012211151200_CIT0060","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2147\/DMSO.S248476","article-title":"Effects of two types of moderate- and high-intensity interval training on serum salusin-alpha and salusin-beta levels and lipid profile in women with overweight\/obesity","volume":"13","author":"Nazari","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2024103012211151200_CIT0061","doi-asserted-by":"crossref","first-page":"300060520903868","DOI":"10.1177\/0300060520903868","article-title":"Salusin-beta is superior to salusin-alpha as a marker for evaluating coronary atherosclerosis","volume":"48","author":"Wang","year":"2020","journal-title":"J Int Med Res"},{"key":"2024103012211151200_CIT0062","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.7754\/Clin.Lab.2016.160136","article-title":"Serum salusin levels in ST-segment elevation myocardial infarction","volume":"62","author":"Yilmaz","year":"2016","journal-title":"Clin Lab"},{"key":"2024103012211151200_CIT0063","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1517\/14728222.2013.819852","article-title":"Anti-salusin-\u03b2 antibody enhances angiogenesis after myocardial ischemia reperfusion injury","volume":"17","author":"Masumura","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"2024103012211151200_CIT0064","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijcard.2018.12.020","article-title":"Silencing salusin beta ameliorates heart failure in aged spontaneously hypertensive rats by ROS-relative MAPK\/NF-kappaB pathways in the paraventricular nucleus","volume":"280","author":"Li","year":"2019","journal-title":"Int J Cardiol"},{"key":"2024103012211151200_CIT0065","doi-asserted-by":"crossref","first-page":"8896226","DOI":"10.1155\/2021\/8896226","article-title":"Knockdown of salusin-beta improves cardiovascular function in myocardial infarction-induced chronic heart failure rats","volume":"2021","author":"Xu","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"2024103012211151200_CIT0066","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1748-1716.2012.02475.x","article-title":"Effects of salusin-beta on action potential and ionic currents in ventricular myocytes of rats","volume":"207","author":"Ren","year":"2013","journal-title":"Acta Physiol (Oxf)"},{"key":"2024103012211151200_CIT0067","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.peptides.2010.03.016","article-title":"Inhibition of L-type calcium currents by salusin-beta in rat cardiac ventricular myocytes","volume":"31","author":"Shi","year":"2010","journal-title":"Peptides"},{"key":"2024103012211151200_CIT0068","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.dsx.2020.10.025","article-title":"Serum salusin-beta in relation to atherosclerosis and ventricular dysfunction in patients with type 2 diabetes mellitus","volume":"14","author":"Yassien","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"2024103012211151200_CIT0069","doi-asserted-by":"crossref","first-page":"e2690","DOI":"10.1038\/cddis.2017.106","article-title":"Salusin-beta contributes to oxidative stress and inflammation in diabetic cardiomyopathy","volume":"8","author":"Zhao","year":"2017","journal-title":"Cell Death Dis"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/75\/3\/363\/60216945\/rgac087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/75\/3\/363\/60216945\/rgac087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T17:15:22Z","timestamp":1730308522000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/75\/3\/363\/6889450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":69,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,1]]},"published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgac087","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2023,3,1]]}}}